1 2 

Minister Chrystia Freeland announced new program to provide up to $50 million over five years in direct financial support to small and medium-sized enterprises (SMEs) seeking to develop export opportunities.

Quest PharmaTech Receives US $2M for its Immuno-Photodynamic Therapy Assets

The "Company of the Year" award was presented to Fedora Pharmaceuticals at BioAlberta's annual Awards Gala in Edmonton on November 24, 2015.

Friday, November 27, 2015

BioAlberta hosted its 16th Annual AGM and Awards Gala in Edmonton, with an audience of over 150 representatives from industry, government and educational institutions. The event recognized companies and individuals ...

Thursday, November 26, 2015

SolAeroMed Inc., announce its completion of patient recruitment for core components of its Phase IIa Proof of Concept data for its S-1226™ technology.


Wednesday, November 18, 2015

Quest PharmaTech’s subsidiary, OncoQuest, Closes US $13M Preferred Share Private Placement with Hepalink USA to Fund Immunotherapy for Treatment of Cancer

Thursday, November 12, 2015

Unique PGX enabling technology expected to generate novel bio-based products with improved purity and functionality in several industrial applications.

Jeremy Webster, Deloitte LLP, and Mel Wong, BioAlberta, will present the findings of the 2015 Alberta State of the Industry Report in Edmonton on November 3rd and in Calgary on November 5th.

Surface Medical's peel-back patches - a Band-Aid to repair damaged hospital beds - applauded!

VaxAlta announces new collaboration with the University of Alberta to advance early stage livestock vaccines research.

Young scientists and entrepreneurs are taking their new water quality detection technology "FRED" to the next stage in California.

TerraVerdae BioWorks Inc. share some of their Summer 2015 good news stories!

Friday, September 4, 2015

FredSense Technologies has developed a solution, called FRED, for Field-Ready Electrochemical Detector.

Tuesday, August 25, 2015

BioNeutra has acquired a manufacturing facility in Edmonton that it will use to start a production line for its specialized food ingredients.

Wednesday, August 12, 2015

An exclusive license agreement between SinoVeda Canada Inc. and Exzell Pharma to commercialize SinoVeda’s patented multi-element calcium supplement.

Wednesday, August 12, 2015

Aquila Diagnostics Inc. announces its participation in a project with the PATH Malaria Vaccine Initiative to improve testing for malaria infectiousness.

Genome Canada is the primary funding and information resource relating to genomics and proteomics research in Canada. A few current funding opportunities are: LSARP, GAPP and DIG.

Tuesday, July 28, 2015

Quest PharmaTech, an Edmonton-based pharmaceutical company developing and commercializing products for the treatment of cancer, announces that it has closed a $1,000,000 unit offering private placement.

Friday, July 17, 2015

GIC, an Edmonton based pharmaceutical manufacturer, perfects ultra-pure nucleoside production for anti-viral and anti-cancer use.

Alberta Innovates Bio Solutions has launched a new funding program, “Alberta Bio Future Product and Technology Commercialization"

Thursday, July 16, 2015

GIC, an Edmonton based pharmaceutical manufacturer has been sold to local Alberta investors.

Wednesday, June 3, 2015

New ingredient for cosmetic facial scrubs to address concerns of freshwater pollution from synthetic, non-degradable plastic microbeads.

1 2